 This statistic displays the global ulcerative colitis market value in 2012, and a forecast for 2022. In 2012, the ulcerative colitis market was valued at 4.2 billion U.S. dollars. Ulcerative colitis is a type of inflammatory bowel disease (IBD) which is characterized by the formation of ulcers in the colon. Approximately, 1 to 1.3 million people currently suffer from IBD, however, the cause of IBD is currently unknown. 